We are live on ! Find out more
RFM

Royal Fund Management Portfolio holdings

AUM $1.2B
1-Year Est. Return 32.21%
This Fund
S&P 500
This Quarter Est. Return
+6.78%
1 Year Est. Return
+32.21%
3 Year Est. Return
+92.42%
5 Year Est. Return
+97.01%
10 Year Est. Return
AUM
$279M
AUM Growth
+$27.7M
Cap. Flow
+$13.4M
Cap. Flow %
4.79%
Top 10 Hldgs %
34.45%
Holding
719
New
225
Increased
172
Reduced
75
Closed
44

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$6.79M
2
GSK icon
GSK
GSK
+$3.54M
3
PPL
PPL Corp
PPL
+$2.33M
4
T icon
AT&T
T
+$968K
5
DEO icon
Diageo
DEO
+$538K

Sector Composition

Rank Sector Weight
1 Consumer Staples 15.3%
2 Technology 14.94%
3 Energy 10.16%
4 Consumer Discretionary 9.72%
5 Healthcare 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFG icon
551
Principal Financial Group
PFG
$24.3B
$3K ﹤0.01%
56
SONY icon
552
Sony
SONY
$137B
$3K ﹤0.01%
+355
New +$3.05K
VALE icon
553
Vale
VALE
$64.1B
$3K ﹤0.01%
+272
New +$2.89K
AUY
554
DELISTED
Yamana Gold, Inc.
AUY
$3K ﹤0.01%
1,000
EPZM
555
DELISTED
Epizyme, Inc
EPZM
$3K ﹤0.01%
282
CERN
556
DELISTED
Cerner Corp
CERN
$3K ﹤0.01%
+53
New +$3.66K
MXIM
557
DELISTED
Maxim Integrated Products
MXIM
$3K ﹤0.01%
+72
New +$3.74K
WPX
558
DELISTED
WPX Energy, Inc.
WPX
$3K ﹤0.01%
224
A icon
559
Agilent Technologies
A
$39.1B
$2K ﹤0.01%
+41
New +$2.77K
AMD icon
560
Advanced Micro Devices
AMD
$776B
$2K ﹤0.01%
228
APH icon
561
Amphenol
APH
$198B
$2K ﹤0.01%
+124
New +$2.73K
APTV icon
562
Aptiv
APTV
$12B
$2K ﹤0.01%
+27
New +$2.57K
ARAY icon
563
Accuray
ARAY
$32M
$2K ﹤0.01%
500
AVY icon
564
Avery Dennison
AVY
$13B
$2K ﹤0.01%
+25
New +$2.7K
BAX icon
565
Baxter International
BAX
$13.5B
$2K ﹤0.01%
+42
New +$2.7K
BCE icon
566
BCE
BCE
$20.2B
$2K ﹤0.01%
+43
New +$2.05K
BIIB icon
567
Biogen
BIIB
$30B
$2K ﹤0.01%
+8
New +$2.57K
BLK icon
568
Blackrock
BLK
$169B
$2K ﹤0.01%
+4
New +$1.94K
BWA icon
569
BorgWarner
BWA
$13.1B
$2K ﹤0.01%
+57
New +$2.63K
C icon
570
Citigroup
C
$222B
$2K ﹤0.01%
+37
New +$2.74K
CBOE icon
571
Cboe Global Markets
CBOE
$32.5B
$2K ﹤0.01%
+23
New +$2.69K
CCEP icon
572
Coca-Cola Europacific Partners
CCEP
$48.3B
$2K ﹤0.01%
+62
New +$2.48K
CCI icon
573
Crown Castle
CCI
$33.3B
$2K ﹤0.01%
+19
New +$2.05K
CNC icon
574
Centene
CNC
$30.7B
$2K ﹤0.01%
+54
New +$2.62K
CXW icon
575
CoreCivic
CXW
$2.96B
$2K ﹤0.01%
125

Similar funds

Royal Fund Management's Q4 2017 Portfolio in Review

As of Q4 2017, Royal Fund Management held 719 positions worth $279M, up 11% from $251M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Royal Fund Management deployed $13.4M of net new capital in Q4 2017, opening 225 new positions and adding to 172 existing holdings. Its largest new stake was State Street SPDR Portfolio S&P 500 ETF: 47,863 shares worth $1.5M.

By sector, the portfolio is most concentrated in Consumer Staples at 15% of assets, up from 15% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Merck, an estimated $6.79M trimmed.

  • Royal Fund Management's largest Q4 2017 buy was State Street SPDR Portfolio S&P 500 ETF: 47,863 shares worth $1.5M.
  • Royal Fund Management added most to IBM in Q4 2017, an estimated $7.47M increase.
  • Royal Fund Management's biggest Q4 2017 reduction was Merck, cutting an estimated $6.79M.
  • Royal Fund Management fully exited iShares US Real Estate ETF in Q4 2017, selling an estimated $104K.
  • Royal Fund Management's ten largest holdings make up 34% of its $279M portfolio in Q4 2017.
  • Royal Fund Management opened 225 new positions and closed 44 in Q4 2017.
  • Royal Fund Management's portfolio value rose 11% quarter-over-quarter to $279M.

Based on Royal Fund Management's 13F filing for Q4 2017, filed 7 May 2020.